A rational approach to androgen therapy for hypogonadal men with prostate cancer.

about

Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.

P2860

Q37218685-DB69B70E-C51E-419A-BCF2-88B41170A71A

P2860

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

Item

http://www.wikidata.org/entity/Q36278639

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@ast

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@en

type

Item

label

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@ast

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@en

prefLabel

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@ast

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@en

P1476

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

@en

P2093

Kaufman J

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy.

Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy.

Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Prostate cancer in men using testosterone supplementation.

The historical origins of interstitial cystitis.

Androgen replacement therapy and prostate safety.

Risks of testosterone-replacement therapy and recommendations for monitoring.

P2888

sj.ijir.3901401

P304

26-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.IJIR.3901401

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7557923

http://www.w3.org/2001/XMLSchema#string

P6179

1032126413

http://www.w3.org/2001/XMLSchema#string

P698

16208401

http://www.w3.org/2001/XMLSchema#string

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

about

P2860

P2860

A rational approach to androgen therapy for hypogonadal men with prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698